Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ghent, Belgium; Product Development, UCB, Braine l'Alleud, Belgium.
Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium.
Int J Pharm. 2019 Oct 5;569:118525. doi: 10.1016/j.ijpharm.2019.118525. Epub 2019 Jul 15.
Many studies on continuous twin-screw granulation only focus on the granulator without linking this process step to the upstream and downstream unit operations. Product critical quality attributes (CQAs) are however not only determined by the granulation step. In this study, the possibility to manage the batch-to-batch variability of an active pharmaceutical ingredient (API) in a high drug loaded formulation on a continuous line was investigated to obtain consistent tablet CQAs. As the ultimate goal of continuous manufacturing is to produce 24/7, current study also aimed at guaranteeing long term stability of the process. To do so, previously identified API critical material attributes (CMAs) were varied together with granulation, drying and milling critical process parameters (CPPs) in a screening design of experiments to understand the influence of these factors upon product CQAs and process stability. To evaluate the factors affecting the process stability with a reduced amount of materials, process deviations recorded by process sensors were used. While product CQAs only depended on process CPPs, process stability was strongly affected by API CMAs. The effect of API batch-to-batch variability on process stability could nonetheless be managed by applying suitable granulation conditions. Therefore, appropriate ranges of CPPs were defined to ensure both product CQAs and process stability. By studying the fully integrated continuous manufacturing line, it was possible to highlight the interactions between the different unit operations and the API CMAs and to design a robust process.
许多关于连续双螺杆造粒的研究仅关注造粒机,而没有将该工艺步骤与上下游单元操作联系起来。然而,产品关键质量属性(CQAs)不仅取决于造粒步骤。在这项研究中,研究了在连续线上管理高载药量配方中活性药物成分(API)批间变异性的可能性,以获得一致的片剂 CQAs。由于连续制造的最终目标是 24/7 生产,因此当前研究还旨在保证工艺的长期稳定性。为此,在筛选实验的设计中,一起改变了先前确定的 API 关键材料属性(CMAs)和造粒、干燥和制粒关键工艺参数(CPPs),以了解这些因素对产品 CQAs 和工艺稳定性的影响。为了使用较少的材料评估影响工艺稳定性的因素,使用工艺传感器记录的工艺偏差。虽然产品 CQAs 仅取决于 CPPs,但工艺稳定性受到 API CMAs 的强烈影响。然而,通过应用合适的造粒条件,可以管理 API 批间变异性对工艺稳定性的影响。因此,定义了合适的 CPP 范围,以确保产品 CQAs 和工艺稳定性。通过研究完全集成的连续制造线,突出了不同单元操作之间的相互作用以及 API CMAs,并设计了一个稳健的工艺。